述评：血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂在糖尿病高血压和非高血压患者中的应用现状。维生素 D 是否有一席之地？
Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?
机构信息
Endocrine and Diabetes Department, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia. E-mail.
出版信息
Saudi Med J. 2021 Jan;42(1):115. doi: 10.15537/smj.2021.1.25621.
Abstract
[No Abstract Available].
摘要
[无摘要可用]。
相似文献
1
Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?述评：血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂在糖尿病高血压和非高血压患者中的应用现状。维生素 D 是否有一席之地？
Saudi Med J. 2021 Jan;42(1):115. doi: 10.15537/smj.2021.1.25621.
2
Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?述评：血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体阻滞剂在糖尿病高血压和非高血压患者中的应用现状。维生素 D 是否有一席之地？
Saudi Med J. 2020 Dec;41(12):1381. doi: 10.15537/smj.2020.12.25571.
3
The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?目前在糖尿病合并高血压和非高血压患者中使用血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体阻滞剂的实践。维生素 D 是否有一席之地？
Saudi Med J. 2020 Oct;41(10):1083-1089. doi: 10.15537/smj.2020.10.25428.
4
Angiotensin-converting enzyme inhibition or angiotensin receptor blockade in hypertensive diabetics?高血压糖尿病患者使用血管紧张素转换酶抑制剂还是血管紧张素受体阻滞剂？
Curr Hypertens Rep. 2003 Oct;5(5):364-7. doi: 10.1007/s11906-003-0080-3.
5
The role of angiotensin receptor blockers in diabetic nephropathy.血管紧张素受体阻滞剂在糖尿病肾病中的作用。
Postgrad Med. 2011 May;123(3):109-21. doi: 10.3810/pgm.2011.05.2289.
6
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.糖尿病肾病中肾素-血管紧张素系统的单药与联合阻断治疗（血管紧张素转换酶抑制剂和/或血管紧张素II受体阻滞剂）
Curr Opin Nephrol Hypertens. 2004 May;13(3):319-24. doi: 10.1097/00041552-200405000-00009.
7
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].[血管紧张素转换酶抑制剂对慢性肾衰竭进展的影响]
Presse Med. 2002 Nov 9;31(36):1714-20.
8
Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for renal outcomes and mortality in diabetic kidney disease.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂对糖尿病肾病患者肾脏结局和死亡率的影响比较
Eur J Intern Med. 2021 Mar;85:127-129. doi: 10.1016/j.ejim.2020.11.017. Epub 2020 Nov 26.
9
Combination use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in diabetic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在糖尿病肾病中的联合应用。
Curr Diab Rep. 2013 Aug;13(4):567-73. doi: 10.1007/s11892-013-0391-y.
10
Renoprotective effects of renin-angiotensin-aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis.肾素-血管紧张素-醛固酮系统阻滞剂在2型糖尿病中的肾脏保护作用：在网络荟萃分析中解读多重治疗比较
Diabetologia. 2012 Sep;55(9):2547-8; author reply 2549-50. doi: 10.1007/s00125-012-2619-9. Epub 2012 Jun 23.
本文引用的文献
1
The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?目前在糖尿病合并高血压和非高血压患者中使用血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体阻滞剂的实践。维生素 D 是否有一席之地？
Saudi Med J. 2020 Oct;41(10):1083-1089. doi: 10.15537/smj.2020.10.25428.
2
Vitamin D Deficiency and Associated Risk Factors in Women from Riyadh, Saudi Arabia.沙特阿拉伯利雅得的妇女维生素 D 缺乏及相关危险因素。
Sci Rep. 2019 Dec 30;9(1):20371. doi: 10.1038/s41598-019-56830-z.
3
Introduction: .引言：.
Diabetes Care. 2020 Jan;43(Suppl 1):S1-S2. doi: 10.2337/dc20-Sint.
4
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
5
Combined angiotensin inhibition for the treatment of diabetic nephropathy.联合应用血管紧张素抑制剂治疗糖尿病肾病。
N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9.
6
Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark.新诊断的中老年糖尿病患者肾脏受累的流行病学。来自丹麦基于人群的研究“全科医疗中的糖尿病护理”的横断面数据。
Diabetologia. 1993 Oct;36(10):1007-16. doi: 10.1007/BF02374492.
Zotero 插件